somebody else doing something similar
Maybe some here will eventually get the reason we , and others, are saying goodbye to ASXKazia to de-list from ASX
Oncology-focused drug development company Kazia Therapeutics (ASX:KZA) has surprisingly announced its intention to de-list from the ASX.
Kazia says its board has ultimately determined that the costs, administrative burden and commercial disadvantages of remaining listed on ASX outweigh any benefits of a continued listing.
The company says continued listing would incur considerable costs, including listing fees, at a time when Kazia is seeking to minimise its expenditure.
Further, the board believes that delisting from ASX whilst retaining its NASDAQ listing will enable Kazia to have access to a deeper market that better understands and values biotech businesses, thereby allowing it to more readily raise more capital on better terms from a wider investor base.
Aussie shareholders will be able to sell their ASX shares now, or wait for conversion into NASDAQ shares.
Kazia has an ongoing Phase 2 study (PNOC022, NCT05009992) of paxalisib, an investigational drug for the treatment of diffuse intrinsic pontine glioma (DIPG) and other diffuse midline gliomas (DMGs).
- Forums
- ASX - By Stock
- General discussion
somebody else doing something similarMaybe some here will...
-
- There are more pages in this discussion • 2,256 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)